Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Research progress on exosomes in the otology field: a systematic review

Hao Z., Zhang C., Li Z., Zhao H., Wang Y., Wang Y.

Systematic Review, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Stem Cell Res Ther (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41327268
PMCID
PMC12777064
DOI
10.1186/s13287-025-04816-2

Abstract (original English)

Exosomes, characterized by their distinctive structural and functional properties, are increasingly recognized as an important focus of research in otology, offering considerable promise for both diagnostic and therapeutic purposes. This review provides a systematic summary of the biological foundations of exosomes, with particular emphasis on their potential applications in the diagnosis and treatment of ear diseases. We begin by evaluating the translational utility of exosomes as biomarkers for the early detection of otologic diseases. We then explore the therapeutic mechanisms mediated by exosomes derived from mesenchymal stem cells (MSCs), various tissues, body fluids, and plant sources. Owing to their natural capacity to encapsulate biological cargo, exosomes represent highly promising delivery vehicles capable of efficiently transporting drugs, functional proteins, and nucleic acids to target sites within the ear, thereby offering innovative avenues for the treatment of otological conditions. Finally, this review outlines prospective research directions and critically examines the major scientific challenges that must be addressed to facilitate clinical translation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
Mesenchymal Stem CellsAnimalsHumansEar DiseasesExosomesBiomarkers

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.